Drug recall · September 28, 2016
Mozobil recall
Why: Labeling: Incorrect or Missing Lot and/or Exp. Date
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01
- Lots / codes
Lot # 5RZ002; Exp. 04/18
- Quantity
- 9,530 vials
- Company
- Genzyme Corporation / Genzyme Biosurgery, Ridgefield, NJ
- Distribution
- nationwide
- Initiated
- August 4, 2016 · Voluntary: Firm initiated
- Classified
- September 22, 2016
- Reported
- September 28, 2016
- Ended
- April 19, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Plerixafor
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.